Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Durez

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaireBoulos Haraoui, Josef S Smolen, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
Lancet (London, England)|January 24, 2021
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Patrick Durez, Maya H Buch, et al.
Annals of the Rheumatic Diseases|August 2, 2011
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaireBoulos Haraoui, Josef S Smolen, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registryPedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
The Lancet. Rheumatology|January 22, 2024
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trialsFelice Rivellese, Alessandra Nerviani, Giovanni Giorli, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|May 14, 2015
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceJosef S Smolen, Ferdinand C Breedveld, Gerd R Burmester, et al.
Pageof 12